Published in Br J Cancer on December 01, 1999
Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings. Cancer Detect Prev (2007) 0.96
Nipple aspirate fluid and ductoscopy to detect breast cancer. Diagn Cytopathol (2010) 0.88
Does mammary ductoscopy have a role in clinical practice? Int Semin Surg Oncol (2006) 0.87
Nipple aspirate cytology and pathologic parameters predict residual cancer and nodal involvement after excisional breast biopsy. Br J Cancer (2001) 0.81
Expression of epidermal growth factor, transforming growth factor-β1 and adiponectin in nipple aspirate fluid and plasma of pre and post-menopausal women. Biomark Res (2013) 0.78
Nipple aspirate fluid producer status among premenopausal women in Hawaii. Breast J (2012) 0.78
Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer. Environ Health Perspect (2002) 0.78
Paired ductal carcinoma in situ and invasive breast cancer lesions in the D-loop of the mitochondrial genome indicate a cancerization field effect. Biomed Res Int (2012) 0.77
CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis. PLoS One (2016) 0.76
Cytology in nipple aspirate fluid during a randomized soy food intervention among premenopausal women. Nutr Cancer (2013) 0.75
Bioinformatics analysis of dysregulated microRNAs in the nipple discharge of patients with breast cancer. Oncol Lett (2017) 0.75
The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci U S A (1969) 6.09
Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer (1978) 2.23
Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer (1990) 2.01
Therapy of small breast cancer: a prospective study on 1036 patients with special emphasis on prognostic factors. Int J Radiat Oncol Biol Phys (1992) 1.96
DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer (1988) 1.75
Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer (1997) 1.69
Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat (1995) 1.63
Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev (1996) 1.52
Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol (1992) 1.48
Nipple aspirate cytology for the study of breast cancer precursors. J Natl Cancer Inst (1983) 1.44
Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg (1993) 1.27
Late cosmetic outcome after conservative surgery and radiotherapy: analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys (1989) 1.26
Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nepple aspiration. J Natl Cancer Inst (1975) 1.21
Cellular composition of the nipple aspirate specimen of breast fluid. I. The benign cells. Am J Clin Pathol (1975) 1.15
Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer (1987) 1.13
Lumpectomy and level I axillary dissection prior to irradiation for "operable" breast cancer. Ann Surg (1984) 1.05
Assay reproducibility of hormone measurements in postmenopausal women. Cancer Epidemiol Biomarkers Prev (1997) 1.03
Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer (1989) 1.02
Quantitative DNA analysis of fresh solid tumors by flow and image cytometric methods: a comparison using the Roche Pathology Workstation Image Analyzer. Mod Pathol (1995) 0.98
Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann Surg (1993) 0.91
Pathologic features related to local recurrence following lumpectomy and irradiation. Semin Surg Oncol (1992) 0.88
Limited resection for breast cancer: a study of inked specimen margins before radiotherapy. Int J Radiat Oncol Biol Phys (1987) 0.87
Immunofluorometric assay of prostaglandin D synthase in human tissue extracts and fluids. Clin Chem (1996) 0.87
Implications of accurate pathologic margins in the treatment of primary breast cancer. Arch Surg (1989) 0.86
Relationship between epidermal growth factor and dehydroepiandrosterone and its sulphate in breast cyst fluid. Br J Cancer (1989) 0.83
Breast conserving surgery and definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys (1989) 0.82
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst (1998) 22.10
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet (2000) 15.19
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Duplication of CaMV 35S Promoter Sequences Creates a Strong Enhancer for Plant Genes. Science (1987) 6.00
Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med (2000) 5.58
The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell (1994) 5.21
Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA (1997) 4.79
Intramolecular integration within Moloney murine leukemia virus DNA. J Virol (1981) 3.77
Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med (2000) 3.74
Identification of bile duct stones in patients undergoing laparoscopic cholecystectomy. Br J Surg (1991) 3.65
Life expectancy, economic inequality, homicide, and reproductive timing in Chicago neighbourhoods. BMJ (1997) 3.56
Psychological and behavioral implications of abnormal mammograms. Ann Intern Med (1991) 3.40
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med (1996) 3.07
Factors associated with repeat adherence to breast cancer screening. Prev Med (1990) 3.01
BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet (1996) 2.75
Why women resist screening mammography: patient-related barriers. Radiology (1989) 2.57
Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol (1994) 2.52
Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet (1996) 2.48
Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst (1995) 2.45
Safety and efficacy of adjunctive balloon remodeling during endovascular treatment of intracranial aneurysms: a literature review. AJNR Am J Neuroradiol (2008) 2.40
Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer (1998) 2.36
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet (1999) 2.36
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J Natl Cancer Inst (1998) 2.33
Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J (2001) 2.30
Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. J Clin Oncol (1985) 2.26
The Goldman algorithm revisited: prospective evaluation of a computer-derived algorithm versus unaided physician judgment in suspected acute myocardial infarction. Am Heart J (1999) 2.19
The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis. Oncogene (2009) 2.14
Intravenous regional block using ketorolac: preliminary results in the treatment of reflex sympathetic dystrophy. Anesth Analg (1992) 2.13
Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst (1993) 2.07
Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet (2012) 2.06
Detection of perchlorate and the soluble chemistry of martian soil at the Phoenix lander site. Science (2009) 2.01
Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet (2000) 1.93
Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis. Clin Sci (Lond) (1992) 1.88
Comparison of the reflex responses elicited by stimulation of the separately perfused carotid and aortic body chemoreceptors in the dog. J Physiol (1966) 1.87
Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am (2006) 1.86
One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. Circulation (1992) 1.82
Lower-than-expected linkage disequilibrium between tightly linked markers in humans suggests a role for gene conversion. Am J Hum Genet (2001) 1.80
Why do some women get regular mammograms? Am J Prev Med (1991) 1.78
Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer (1992) 1.78
Exceptional familial clustering for extreme longevity in humans. J Am Geriatr Soc (2000) 1.69
Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study. Cancer (1993) 1.69
Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer (1997) 1.69
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer (1992) 1.68
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol (1995) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
The value and limitations of aspiration cytology in the diagnosis of primary tumors. A symposium. Acta Cytol (1990) 1.63
Promoting mammography use through progressive interventions: is it effective? Am J Public Health (1994) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Malignant melanoma in transgenic mice. Proc Natl Acad Sci U S A (1991) 1.58
Aspiration cytology of papillary cystic neoplasm of the pancreas. Am J Clin Pathol (1990) 1.57
Letter: Plasma-propranolol levels in inflammation disease. Lancet (1976) 1.57
Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol (2007) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection. Aliment Pharmacol Ther (2006) 1.54
Non-invasive detection of hypoglycaemia using a novel, fully biocompatible and patient friendly alarm system. BMJ (2001) 1.53
Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev (1996) 1.52
Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys (2000) 1.52
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2001) 1.51
Breast screening practices among primary physicians: reality and potential. J Am Board Fam Pract (1990) 1.50
Fine-needle aspiration biopsy of suspected intraocular tumors. The 1992 Urwick Lecture. Ophthalmology (1993) 1.50
Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins. J Virol (1989) 1.49
Stent-supported aneurysm coiling: a literature survey of treatment and follow-up. AJNR Am J Neuroradiol (2011) 1.48
Mutation affecting thermostability of sigma subunit of Escherichia coli RNA polymerase lies near the dnaG locus at about 66 min on the E. coli genetic map. Proc Natl Acad Sci U S A (1978) 1.48
Atypical retinal astrocytic hamartoma diagnosed by fine-needle biopsy. Ophthalmology (1996) 1.46
A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol (1986) 1.46
Local excision and chemoradiation for low rectal T1 and T2 cancers is an effective treatment. Am Surg (1999) 1.45
Assessment of postoperative pain management: patient satisfaction and perceived helpfulness. Clin J Pain (1997) 1.45
Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol (1984) 1.44
Brachial plexus block with a new local anaesthetic: 0.5 per cent ropivacaine. Can J Anaesth (1990) 1.44
Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease. Br Med J (1976) 1.43
Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol (1992) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Intraoperative ultrasound does not improve detection of liver metastases in resectable pancreatic cancer. Am J Surg (1998) 1.41
Spousal homicide risk and estrangement. Violence Vict (1993) 1.40
Mice develop normally without the H1(0) linker histone. Proc Natl Acad Sci U S A (1995) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Methotrexate mishap. Br J Rheumatol (1994) 1.38
Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. Health Psychol (1995) 1.37
Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.36
A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style. Health Psychol (1996) 1.36
Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Dev Med Child Neurol (1982) 1.36
Guilt by association. Nat Genet (2000) 1.36
Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population. J Gastrointest Surg (2000) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2004) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Origin of the magnetoelectric coupling effect in Pb(Zr0.2Ti0.8)O{3}/La{0.8}Sr{0.2}MnO{3} Multiferroic heterostructures. Phys Rev Lett (2010) 1.32
Communication between patients with breast cancer and health care providers. Determinants and implications. Cancer (1993) 1.30
Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys (1999) 1.29
Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res (1999) 1.28